DreaMed is pioneering AI - transforming patient data into expert level treatment recommendations personalized for each patient. They are the world's first and only company to receive FDA clearance for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps. Their founders are all physicians and engineers. Their products are developed based on real insights from the clinical practice of diabetes specialists, physicians, and clinical researchers from the top diabetes centers worldwide.